N. Valeska Halstead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
N. Valeska Halstead has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Nicholas G. Cost
University of Colorado Anschutz Medical Campus, Children's Hospital of Colorado, Division of Pediatric Urology, Aurora, CO
3 shared publications- Abby S. Taylor
Monroe Carell Jr Children’s Hospital at Vanderbilt Nashville, Tennessee
1 shared publication - Amanda F. Saltzman
University of Kentucky, Department of Urology, Lexington, KY
1 shared publication Carrye R. Cost
University of Colorado School of Medicine, Children's Hospital of Colorado, Department of Pediatric Hematology/Oncology/Bone Marrow Transplant, Aurora, CO
1 shared publication- Dan Wood
Department of Surgery‐Urology University of Colorado School of Medicine Aurora CO USA
1 shared publication - Darren Ha
Pediatric Urology Research Enterprise, Department of Pediatric Urology, Children's Hospital Colorado, Aurora, CO, USA; University of Colorado School of Medicine, Aurora, CO, USA
1 shared publication
Latest Publications
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (4) , 610-617
Pediatric Urologists’ Views on the U.S. News & World Report Rankings
To understand the general attitudes of pediatric urologists regarding the United States News and World Report rankings for Best Children's Hospitals in Urology. We performed a cross-sectional survey study distributed via email to active and candidate members of the Societies of Pediatric Urology from October 2022 to December 2022. This anonymous survey was iteratively developed to contain multiple choice questions gathering information on demographics, personal interaction with the rankings system, and about attitudes towards the rankings across various domains. Of the 515 members surveyed, 264 pediatric urologists responded to the survey for a response rate of 51%. There was representation from all sections of the American Urological Association and across all age categories and practice models. Overall, of the respondents, 71% disagreed that the rankings had led to improvements in care, and 75% disagreed that programs were reporting their data honestly. Additionally, 71% believed the rankings are inaccurate in reflecting patient outcomes. The majority (86%) of respondents stated they would support organized efforts to withdraw from the rankings. This was significantly different by ranking cohort, with 78% from top 10 programs endorsing withdrawal vs 89% from those programs not in the top 10. Our survey found that most pediatric urologists would support efforts to withdraw from participating in the rankings and believe that programs are dishonest in reporting their data. The majority also do not believe a survey can adequately distinguish between programs. This highlights a clear need for a critical re-evaluation of the rankings.
- 1 October 2024
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 212 (4) , 610-617
Pediatric Urologists’ Views on the U.S. News & World Report Rankings
To understand the general attitudes of pediatric urologists regarding the United States News and World Report rankings for Best Children's Hospitals in Urology. We performed a cross-sectional survey study distributed via email to active and candidate members of the Societies of Pediatric Urology from October 2022 to December 2022. This anonymous survey was iteratively developed to contain multiple choice questions gathering information on demographics, personal interaction with the rankings system, and about attitudes towards the rankings across various domains. Of the 515 members surveyed, 264 pediatric urologists responded to the survey for a response rate of 51%. There was representation from all sections of the American Urological Association and across all age categories and practice models. Overall, of the respondents, 71% disagreed that the rankings had led to improvements in care, and 75% disagreed that programs were reporting their data honestly. Additionally, 71% believed the rankings are inaccurate in reflecting patient outcomes. The majority (86%) of respondents stated they would support organized efforts to withdraw from the rankings. This was significantly different by ranking cohort, with 78% from top 10 programs endorsing withdrawal vs 89% from those programs not in the top 10. Our survey found that most pediatric urologists would support efforts to withdraw from participating in the rankings and believe that programs are dishonest in reporting their data. The majority also do not believe a survey can adequately distinguish between programs. This highlights a clear need for a critical re-evaluation of the rankings.
- 30 July 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (5) , 1023-1024
Commentary to: Sentiment analysis of U.S. News & World Report Best Children's Hospital urology rankings: A difference in positivity between the public and academic worlds
- 30 July 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (5) , 1023-1024
Commentary to: Sentiment analysis of U.S. News & World Report Best Children's Hospital urology rankings: A difference in positivity between the public and academic worlds
- Open Access
- 16 July 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (5) , 911-920
Risk of acute kidney injury after lower urinary tract reconstruction with early NSAID therapy: A propensity matched retrospective analysis
- 16 July 2024
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 20 (5) , 911-920
Open AccessRisk of acute kidney injury after lower urinary tract reconstruction with early NSAID therapy: A propensity matched retrospective analysis
- 13 April 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (4) , 399.e1-399.e8
Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery – A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology
- 13 April 2023
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 19 (4) , 399.e1-399.e8
Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery – A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology
- Open Access
- 1 March 2021
- Published by AME Publishing Company in AME Medical Journal
- Vol. 6, 2
A narrative review of the surgical principles of primary and post- chemotherapy retroperitoneal lymph node dissection for non- seminomatous germ cell tumors
Testicular cancer is the most common solid malignancy in men 20–40 years old, notably with a slowly increasing prevalence. The survival rate associated with non-seminomatous germ cell tumors (NSGCT) has seen a dramatic improvement over the past several decades. This improvement in survival has been largely attributed to a multidisciplinary approach that includes cisplatin-based chemotherapies and surgical advances in retroperitoneal lymph node dissection (RPLND). While most urologists are comfortable operating in the retroperitoneum and despite the pathologic staging and treatment benefits demonstrated by the RPLND, it remains a technically challenging surgery with a high potential for risk and morbidity even in the most skilled hands. These challenges are especially pronounced in the post-chemotherapy setting due to severe desmoplasia. Therefore, it should be performed by experienced surgeons at high volume centers. Surgeons attempting this surgery should possess a detailed knowledge of retroperitoneal anatomy, lymphatic drainage and associated metastatic pattern, and ability to troubleshoot potential complications should they arise as these are of paramount importance for success of this operation. Laparoscopic and robotic surgical approaches have been gaining traction and are useful for pathologic staging, but there is still insufficient evidence to support these modalities for curative intent. In this review we detail the surgical principles of RPLND.
- 1 March 2021
- Published by AME Publishing Company in AME Medical Journal
- Vol. 6, 2
Open AccessA narrative review of the surgical principles of primary and post- chemotherapy retroperitoneal lymph node dissection for non- seminomatous germ cell tumors
Testicular cancer is the most common solid malignancy in men 20–40 years old, notably with a slowly increasing prevalence. The survival rate associated with non-seminomatous germ cell tumors (NSGCT) has seen a dramatic improvement over the past several decades. This improvement in survival has been largely attributed to a multidisciplinary approach that includes cisplatin-based chemotherapies and surgical advances in retroperitoneal lymph node dissection (RPLND). While most urologists are comfortable operating in the retroperitoneum and despite the pathologic staging and treatment benefits demonstrated by the RPLND, it remains a technically challenging surgery with a high potential for risk and morbidity even in the most skilled hands. These challenges are especially pronounced in the post-chemotherapy setting due to severe desmoplasia. Therefore, it should be performed by experienced surgeons at high volume centers. Surgeons attempting this surgery should possess a detailed knowledge of retroperitoneal anatomy, lymphatic drainage and associated metastatic pattern, and ability to troubleshoot potential complications should they arise as these are of paramount importance for success of this operation. Laparoscopic and robotic surgical approaches have been gaining traction and are useful for pathologic staging, but there is still insufficient evidence to support these modalities for curative intent. In this review we detail the surgical principles of RPLND.
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 84.e1-84.e8
Opioid prescribing patterns following implementation of Enhanced Recovery After Surgery (ERAS) protocol in pediatric patients undergoing lower tract urologic reconstruction
- 1 February 2021
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 17 (1) , 84.e1-84.e8
Opioid prescribing patterns following implementation of Enhanced Recovery After Surgery (ERAS) protocol in pediatric patients undergoing lower tract urologic reconstruction